Hu Li

652 total citations · 1 hit paper
28 papers, 444 citations indexed

About

Hu Li is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Hu Li has authored 28 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 11 papers in Hepatology and 7 papers in Molecular Biology. Recurrent topics in Hu Li's work include Liver Disease Diagnosis and Treatment (11 papers), Hepatitis C virus research (11 papers) and Hepatitis B Virus Studies (5 papers). Hu Li is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Hepatitis C virus research (11 papers) and Hepatitis B Virus Studies (5 papers). Hu Li collaborates with scholars based in China, United States and Japan. Hu Li's co-authors include Zong‐Gen Peng, Jian‐Dong Jiang, Menghao Huang, Jianrui Li, Biao Dong, Nannan Liu, Jinhua Chen, Xiaoqin Lv, Lei Lei and Jian‐Dong Jiang and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and European Journal of Pharmacology.

In The Last Decade

Hu Li

25 papers receiving 437 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bacteroides thetaiotaomicron ameliorates mouse hepatic steatosis through regulating gut microbial composition, gut-liver folate and unsaturated fatty acids metabolism

2024 56 citations Hu Li, Xuekai Wang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hu Li China	12	181	178	109	39	38	28	444
Dongfeng Sun Canada	10	147 0.8×	135 0.8×	91 0.8×	25 0.6×	47 1.2×	15	494
Antonio Gil‐Gómez Spain	13	194 1.1×	269 1.5×	131 1.2×	24 0.6×	28 0.7×	35	539
Shourong Liu China	14	148 0.8×	155 0.9×	57 0.5×	40 1.0×	39 1.0×	52	457
Liyan Wu China	12	144 0.8×	241 1.4×	61 0.6×	25 0.6×	39 1.0×	29	503
Junli Zhang China	8	132 0.7×	165 0.9×	43 0.4×	29 0.7×	40 1.1×	19	348
François Maggiotto France	8	148 0.8×	206 1.2×	99 0.9×	27 0.7×	21 0.6×	9	476
Mei‐Zhu Hong China	9	224 1.2×	214 1.2×	112 1.0×	22 0.6×	60 1.6×	24	549
Ángela Rojas Spain	14	224 1.2×	330 1.9×	194 1.8×	28 0.7×	29 0.8×	42	637
Xiangying Zhang China	13	226 1.2×	116 0.7×	45 0.4×	70 1.8×	27 0.7×	32	454
Ningning Huang China	9	130 0.7×	164 0.9×	114 1.0×	43 1.1×	100 2.6×	14	405

Countries citing papers authored by Hu Li

Since Specialization

Citations

This map shows the geographic impact of Hu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hu Li more than expected).

Fields of papers citing papers by Hu Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hu Li. The network helps show where Hu Li may publish in the future.

Co-authorship network of co-authors of Hu Li

This figure shows the co-authorship network connecting the top 25 collaborators of Hu Li. A scholar is included among the top collaborators of Hu Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hu Li. Hu Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jiang, Xuan, et al.. (2025). Venous Malformations: Unraveling Latest Mechanisms and Bridging Gaps in Targeted Therapy Development. International Journal of Biological Sciences. 21(15). 7013–7028.

Wang, Xuekai, Hu Li, Jianrui Li, et al.. (2025). Berberine dissociates mitochondrial complex I by SIRT3-dependent deacetylation of NDUFS1 to improve hepatocellular glucose and lipid metabolism. Science China Life Sciences. 68(9). 2676–2696.

Pang, Xu, Jianrui Li, Hu Li, et al.. (2024). Isoechinulin B, a natural product from Antarctic fungus, attenuates acute liver injury by inhibiting excessive cell adhesion. European Journal of Pharmacology. 984. 177065–177065.

Li, Hongying, Jianrui Li, Jiayu Li, et al.. (2024). Carrimycin inhibits coronavirus replication by decreasing the efficiency of programmed –1 ribosomal frameshifting through directly binding to the RNA pseudoknot of viral frameshift-stimulatory element. Acta Pharmaceutica Sinica B. 14(6). 2567–2580. 9 indexed citations

Wang, Xuekai, Jianrui Li, Mei Tang, et al.. (2023). Establishment and application of a high-throughput screening model for cell adhesion inhibitors. Frontiers in Pharmacology. 14. 1140163–1140163. 3 indexed citations

Zhu, Jingyang, Mei Tang, Hu Li, et al.. (2023). Design, synthesis and triglyceride-lowering activity of tricyclic matrine derivatives for the intervention of non-alcoholic fatty liver disease. Bioorganic Chemistry. 142. 106925–106925. 3 indexed citations

Chen, Xiaoli, et al.. (2023). Clinical observation and study of local hyperthermia for treating plantar warts: A pilot study with 38 patients. Frontiers in Medicine. 10. 1087659–1087659. 2 indexed citations

Li, Hu, Nannan Liu, Jianrui Li, et al.. (2022). Bicyclol ameliorates advanced liver diseases in murine models via inhibiting the IL-6/STAT3 signaling pathway. Biomedicine & Pharmacotherapy. 150. 113083–113083. 13 indexed citations

Li, Hu, Nannan Liu, Jianrui Li, et al.. (2022). Combined Use of Bicyclol and Berberine Alleviates Mouse Nonalcoholic Fatty Liver Disease. Frontiers in Pharmacology. 13. 843872–843872. 16 indexed citations

10.

Lv, Xiaoqin, Lili Zou, Jiali Tan, et al.. (2020). Aloperine inhibits hepatitis C virus entry into cells by disturbing internalisation from endocytosis to the membrane fusion process. European Journal of Pharmacology. 883. 173323–173323. 13 indexed citations

11.

Huang, Menghao, Hu Li, Jianrui Li, et al.. (2019). Up-regulation of glycolipid transfer protein by bicyclol causes spontaneous restriction of hepatitis C virus replication. Acta Pharmaceutica Sinica B. 9(4). 769–781. 19 indexed citations

12.

Li, Hu, Jianrui Li, Nannan Liu, et al.. (2019). A proof-of-concept study in HCV-infected Huh7.5 cells for shortening the duration of DAA-based triple treatment regimens. Biomedicine & Pharmacotherapy. 116. 108976–108976. 6 indexed citations

13.

Li, Hu, et al.. (2019). Farnesoid X receptor agonist GW4064 indirectly inhibits HCV entry into cells via down-regulating scavenger receptor class B type I. European Journal of Pharmacology. 853. 111–120. 11 indexed citations

14.

Li, Hu, Jianrui Li, Menghao Huang, et al.. (2018). Bicyclol Attenuates Liver Inflammation Induced by Infection of Hepatitis C Virus via Repressing ROS-Mediated Activation of MAPK/NF-κB Signaling Pathway. Frontiers in Pharmacology. 9. 1438–1438. 29 indexed citations

15.

Li, Hu, Menghao Huang, Jian‐Dong Jiang, & Zong‐Gen Peng. (2018). Hepatitis C: From inflammatory pathogenesis to anti-inflammatory/hepatoprotective therapy. World Journal of Gastroenterology. 24(47). 5297–5311. 68 indexed citations

16.

Huang, Huijie, Hu Li, Wenjia Zhu, et al.. (2018). The activation of STIM1 mediates S-phase arrest and cell death in paraquat induced acute lung intoxication. Toxicology Letters. 292. 123–135. 21 indexed citations

17.

Li, Jianrui, Wenjing Li, Junjun Cheng, et al.. (2017). A Simple but Accurate Method for Evaluating Drug-Resistance in Infectious HCVcc System. BioMed Research International. 2017. 1–9. 4 indexed citations

18.

Li, Jianrui, Menghao Huang, Junjun Cheng, et al.. (2017). Internal driving factors leading to extrahepatic manifestation of the hepatitisï¿½C virus infection. International Journal of Molecular Medicine. 40(6). 1792–1802. 5 indexed citations

19.

Cheng, Junjun, Jianrui Li, Menghao Huang, et al.. (2016). CD36 is a co-receptor for hepatitis C virus E1 protein attachment. Scientific Reports. 6(1). 21808–21808. 47 indexed citations

20.

Cui, Juan, Lianyi Han, Hu Li, et al.. (2006). Computer prediction of allergen proteins from sequence-derived protein structural and physicochemical properties. Molecular Immunology. 44(4). 514–520. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact